BCL2 and hepatocellular carcinoma: The relevant results showed that increasing in the expression of BNIP3 following the treatment of hepatoma cells with concanavalin A inhibited the expression of Bcl‐2/Bcl‐2‐associated X protein ratio, resulting in mitochondrial dysfunction and the activation of caspase‐dependent apoptosis.